Please assess the completion status of the following clinical trial:

Trial Title: Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Japanese chronic systolic heart failure patients with LVEF =\<30% by echocardiography and NYHA II or more~* Patients who receive standard therapy (Angiotensin converting enzyme inhibitors, angiotensin receptor blockers, beta-blocker or diuretic)~Exclusion Criteria:~* Patients with a myocardial infarction, stroke, cardiac surgery or percutaneous coronary intervention within 30 days prior to randomization.~* Patients with serum potassium \>5.0 mmol/L or eGFR \<30 ml/min/1.73 m2.

- Gender: ALL
- Minimum Age: 55 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Eplerenone arm (Type: EXPERIMENTAL): Add on standard heart failure therapy
- Placebo arm (Type: PLACEBO_COMPARATOR): Add on standard heart failure therapy

Based on this trial design, predict the completion outcome and termination type (if applicable).